Toxicoproteomics — a new preclinical tool
- 1 April 2002
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 7 (7) , 411-418
- https://doi.org/10.1016/s1359-6446(02)02211-0
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m2) cyclophosphamideBone Marrow Transplantation, 2001
- Integrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic NetworkScience, 2001
- Advances in molecular toxicology–towards understanding idiosyncratic drug toxicityToxicology, 2000
- Gene Expression Microarray Data Analysis for Toxicology ProfilingAnnals of the New York Academy of Sciences, 2000
- The Principles and Practice of Toxicogenomics: Applications and OpportunitiesToxicological Sciences, 2000
- Proteomic analysis of the renal effects of simulated occupational jet fuel exposureElectrophoresis, 2000
- Cardiotoxicity of Chemotherapeutic AgentsDrug Safety, 2000
- Proteome and proteomics: New technologies, new concepts, and new wordsElectrophoresis, 1998
- A protein expression database for the molecular pharmacology of cancerElectrophoresis, 1997
- Simultaneous Measurement of Hundreds of Liver Proteins: Application in Assessment of Liver FunctionToxicologic Pathology, 1996